Literature DB >> 6723666

Rat-liver lysosomal sialidase. Solubilization, substrate specificity and comparison with the cytosolic sialidase.

T Miyagi, S Tsuiki.   

Abstract

Purified liver lysosomes, prepared from rats previously injected with Triton WR-1339, exhibited sialidase activity towards sialyllactose, fetuin, submaxillary mucin (bovine) and gangliosides, and could be disrupted hypotonically with little loss in these activities. After centrifugation, the activities with sialyllactose and fetuin were largely recovered in the supernatant, demonstrating that they were originally in the intralysosomal space. The activities towards submaxillary mucin and gangliosides, on the other hand, remained in the pellet. In the supernatant, activity with fetuin or orosomucoid was markedly reduced by protease inhibitors, suggesting that proteolysis of these glycoproteins may be prerequisite to sialidase activity. The intralysosomal sialidase was solubilized from the mitochondrial-lysosomal fraction of rat liver and partially purified by Sephadex G-200, or Sephadex G-200 followed by CM-cellulose. The enzyme was maximally active at pH 4.7 with sialyllactose as substrate and had a minimum relative molecular mass of 60 000 +/- 5000 by gel filtration; it hydrolyzed a variety of sialooligosaccharides , those containing (alpha 2----3)sialyl linkages being better substrates than those with (alpha 2----6)sialyl linkages. The enzyme failed to attack submaxillary mucin and gangliosides. It was also inactive towards fetuin, orosomucoid and transferrin but capable of hydrolyzing glycopeptides from pronase digest of fetuin. In contrast to the intralysosomal sialidase, the sialidase partially purified from rat liver cytosol by (NH4)2SO4 fractionation followed by chromatography on DEAE-cellulose and CM-cellulose hydrolyzed fetuin and orosomucoid to the extent about half that for sialyllactose. The enzyme was maximally active at pH 5.8 and had a relative molecular mass of approximately 60 000. It also hydrolyzed gangliosides but not submaxillary mucin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6723666     DOI: 10.1111/j.1432-1033.1984.tb08159.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  25 in total

1.  Decrease in cell surface sialic acid in etoposide-treated Jurkat cells and the role of cell surface sialidase.

Authors:  Y Azuma; A Taniguchi; K Matsumoto
Journal:  Glycoconj J       Date:  2000-05       Impact factor: 2.916

Review 2.  Sialidase significance for cancer progression.

Authors:  Taeko Miyagi; Kohta Takahashi; Keiko Hata; Kazuhiro Shiozaki; Kazunori Yamaguchi
Journal:  Glycoconj J       Date:  2012-05-29       Impact factor: 2.916

3.  On the multiplicity of the enzyme catalase in mammalian liver.

Authors:  C Masters; M Pegg; D Crane
Journal:  Mol Cell Biochem       Date:  1986-05       Impact factor: 3.396

4.  Cellular localization and substrate specificity of isoelectric forms of human liver neuraminidase activity.

Authors:  J Spaltro; J A Alhadeff
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

5.  Sialylation and desialylation dynamics of monocytes upon differentiation and polarization to macrophages.

Authors:  Dan Wang; Evgeny Ozhegov; Lin Wang; Aimin Zhou; Huan Nie; Yu Li; Xue-Long Sun
Journal:  Glycoconj J       Date:  2016-04-14       Impact factor: 2.916

6.  Degradation of G(M1) and G(M2) by mammalian sialidases.

Authors:  S C Li; Y T Li; S Moriya; T Miyagi
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

7.  Evidence for mitochondrial localization of a novel human sialidase (NEU4).

Authors:  Kazunori Yamaguchi; Keiko Hata; Koichi Koseki; Kazuhiro Shiozaki; Hirotoshi Akita; Tadashi Wada; Setsuko Moriya; Taeko Miyagi
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

8.  Defective membrane expression of human growth hormone (GH) receptor causes Laron-type GH insensitivity syndrome.

Authors:  P Duquesnoy; M L Sobrier; S Amselem; M Goossens
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

9.  Differential effect of various inhibitors on four types of rat sialidase.

Authors:  T Miyagi; K Hata; A Hasegawa; T Aoyagi
Journal:  Glycoconj J       Date:  1993-02       Impact factor: 2.916

Review 10.  Sialidase and malignancy: a minireview.

Authors:  Taeko Miyagi; Tadashi Wada; Kazunori Yamaguchi; Keiko Hata
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.